The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States

Yuehan Zhang, Tracey E. Wilson, Adebola Adedimeji, Daniel Merenstein, Joel Milam, Jennifer Cohen, Mardge Cohen, Elizabeth Golub

Research output: Contribution to journalArticle

Abstract

Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95%) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95% CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95% CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95% CI: 1.11–1.97) and other drug use (aPR = 1.87, 95% CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalAIDS and Behavior
DOIs
StateAccepted/In press - May 30 2017

Fingerprint

Cannabis
HIV
Tablets
Pharmaceutical Preparations
Street Drugs
Therapeutics
Demography
Research

Keywords

  • Adherence
  • Antiretroviral therapy
  • Marijuana
  • Substance use
  • Women

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States. / Zhang, Yuehan; Wilson, Tracey E.; Adedimeji, Adebola; Merenstein, Daniel; Milam, Joel; Cohen, Jennifer; Cohen, Mardge; Golub, Elizabeth.

In: AIDS and Behavior, 30.05.2017, p. 1-13.

Research output: Contribution to journalArticle

Zhang, Yuehan ; Wilson, Tracey E. ; Adedimeji, Adebola ; Merenstein, Daniel ; Milam, Joel ; Cohen, Jennifer ; Cohen, Mardge ; Golub, Elizabeth. / The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States. In: AIDS and Behavior. 2017 ; pp. 1-13.
@article{7353f88c4e4b4130a6085b553c21ce61,
title = "The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States",
abstract = "Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95{\%}) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95{\%} CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95{\%} CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95{\%} CI: 1.11–1.97) and other drug use (aPR = 1.87, 95{\%} CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.",
keywords = "Adherence, Antiretroviral therapy, Marijuana, Substance use, Women",
author = "Yuehan Zhang and Wilson, {Tracey E.} and Adebola Adedimeji and Daniel Merenstein and Joel Milam and Jennifer Cohen and Mardge Cohen and Elizabeth Golub",
year = "2017",
month = "5",
day = "30",
doi = "10.1007/s10461-017-1808-4",
language = "English (US)",
pages = "1--13",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",

}

TY - JOUR

T1 - The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States

AU - Zhang, Yuehan

AU - Wilson, Tracey E.

AU - Adedimeji, Adebola

AU - Merenstein, Daniel

AU - Milam, Joel

AU - Cohen, Jennifer

AU - Cohen, Mardge

AU - Golub, Elizabeth

PY - 2017/5/30

Y1 - 2017/5/30

N2 - Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95%) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95% CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95% CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95% CI: 1.11–1.97) and other drug use (aPR = 1.87, 95% CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.

AB - Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95%) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95% CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95% CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95% CI: 1.11–1.97) and other drug use (aPR = 1.87, 95% CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.

KW - Adherence

KW - Antiretroviral therapy

KW - Marijuana

KW - Substance use

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85019767402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019767402&partnerID=8YFLogxK

U2 - 10.1007/s10461-017-1808-4

DO - 10.1007/s10461-017-1808-4

M3 - Article

SP - 1

EP - 13

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

ER -